missing translation for 'onlineSavingsMsg'
Learn More

R&D Systems™ DX3-213B

Catalog No. 807010
Change view
Click to view available options
Quantity:
10 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
807010 10 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 807010 Supplier R&D Systems™ Supplier No. 8070/10

Please call Customer Service at 1-800-234-7437 or send an email to help@thermofisher.com for assistance.

A Tocris product, part of R&D Systems. Potent NDUFS7 antagonist

DX3-213B is a potent oxidative phosphorylation (OXPHOS) complex I (also known as NDUFS7) antagonist (IC50 = 3.6 nM). DX3-213B impairs ATP generation (IC50 = 11 nM) and inhibits the proliferation of MIA PaCa-2 cells (IC50 = 9 nM) in galactose-containing media. In vivo, DX3-213B significantly delays tumor growth in a syngeneic mouse model of pancreatic cancer. DX3-213B is orally bioavailable.

Specifications

Chemical Name or Material (4,4-Difluoro-1-piperidinyl)[(3R)-1-[[4-[(1-methylethyl)sulfonyl]phenyl]sulfonyl]-3-piperidinyl]methanone
CAS 2749555-66-4
Quantity 10 mg
Product Line Tocris
Target Oxidative Phosphorylation Inhibitors
Molecular Formula C20H28F2N2O5S2
Purity 0.97